In this study, we showed that melatonin treatment reduced the tumor growth in a xenograft breast cancer model, and consistent with its reduction, melatonin was able to increase the protein expression of cleaved caspase-3, which is the main inducer of apoptosis. The gene discussed is CASP3; the disease is breast carcinoma.